Trevi Therapeutics Inc. (TRVI)
undefined
undefined%
At close: undefined
4.17
0.00%
After-hours Dec 13, 2024, 07:58 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -29.07M -29.15M -33.94M -32.76M -26.05M -20.55M -12.86M -11.09M
Depreciation & Amortization 123.00K 43.00K 50.00K 47.00K 39.00K 23.00K 4.00K 4.00K
Stock-Based Compensation 2.25M 2.33M 2.54M 2.42M 1.13M 496.00K 205.00K 142.00
Other Working Capital -2.80M -1.24M 678.00K 641.00K 799.00K -634.00K 630.00K -421.00K
Other Non-Cash Items -1.17M -162.00K 974.00K 227.00K 215.00K 2.30M 2.60M 2.45M
Deferred Income Tax - - -82.00K 9.00K - - 1.35M -
Change in Working Capital -3.85M -1.23M 1.51M 1.06M 1.58M -568.00K 722.00K -1.49M
Operating Cash Flow -31.71M -28.18M -28.95M -29.00M -23.09M -18.29M -7.97M -11.19M
Capital Expenditures -137.00K -159.00K - -32.00K -9.00K -158.00K -13.00K -
Acquisitions - -829.00K - - - - - -
Purchase of Investments -9.93M -126.22M - - - - - -
Sales Maturities Of Investments 69.50M 19.00M - - - - - -
Other Investing Acitivies - 829.00K - -32.00K -9.00K - - -
Investing Cash Flow 59.43M -107.37M - -32.00K -9.00K -158.00K -13.00K -
Debt Repayment -9.50M -5.83M - 14.00M - -4.81M -8.25M 8.60M
Common Stock Repurchased - - - - - -1.53M - -
Dividend Paid - - - - -2.24M - - -
Other Financial Acitivies -116.00K 11.73M -408.00K -415.00K 10.35M 9.98M 29.97M -
Financial Cash Flow -7.91M 111.31M 20.77M 16.72M 73.21K 3.63K 21.72M 8.60M
Net Cash Flow 19.81M -24.24M -8.17M -12.31M 50.11M -14.82M 13.73M -2.60M
Free Cash Flow -31.85M -28.33M -28.95M -29.03M -23.10M -18.45M -7.99M -11.19M